This trial studies health outcomes after treatment in patients with retinoblastoma. Gathering health information over time from patients and family members through vision assessments, samples of tissue and saliva, and questionnaires may help doctors learn more about what causes retinoblastoma, identify long-term health outcomes for patients with retinoblastoma, and find out which therapies may be the best for treating retinoblastoma
Retinoblastoma, Cancer Survivor, Biological Sibling, Intraocular Retinoblastoma, Unilateral Retinoblastoma
This trial studies health outcomes after treatment in patients with retinoblastoma. Gathering health information over time from patients and family members through vision assessments, samples of tissue and saliva, and questionnaires may help doctors learn more about what causes retinoblastoma, identify long-term health outcomes for patients with retinoblastoma, and find out which therapies may be the best for treating retinoblastoma
Studying Health Outcomes After Treatment in Patients With Retinoblastoma
-
Lurie Children's Hospital, Chicago, Illinois, United States, 60611
University of Illinois, Chicago, Chicago, Illinois, United States, 60612
University of Minnesoa, Minneapolis, Minnesota, United States, 55455
Washington School of Medicine at St. Louis, Saint Louis, Missouri, United States, 63110
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States, 45229
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States, 19104
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States, 37232
MD Anderson Cancer Center, Houston, Texas, United States, 77030
Texas Childeren's Hospital, Houston, Texas, United States, 77030
Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States, 53226
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
to
ALL
Yes
Vanderbilt-Ingram Cancer Center,
Debra Friedman, MD, PRINCIPAL_INVESTIGATOR, Vanderbilt Medical Center
2031-01